Should You Buy SIGA Technologies, Inc. Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, SIGA Technologies, Inc. (SIGA) scores a robust 8.4/10 on our 32-signal Quality of Company framework. At the current market price of $2.98 and a $214M market cap, our analysis maps this fundamental strength against 13 institutional-grade models to determine if a sufficient margin of safety exists.
The short answer: 9 of 10 CirclFi valuation models project upside for SIGA Technologies, Inc. (SIGA) at $2.98 — the model consensus leans bullish, with a Quality Score of 8.4/10 and Value-Trap risk of 31/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
What Is the Investment Case for SIGA Technologies, Inc. (SIGA) in 2026?
What Is the Bull Case vs the Bear Case for SIGA Technologies, Inc. (SIGA)?
| Bull case — $12.41 target (+316.4%) | Bear case — $1.76 target (-41.0%) |
|---|---|
| According to the CirclFi Quality of Company (QOC) framework, SIGA Technologies, Inc.'s score of 8.4/10 reflects durable competitive advantages that should sustain earnings power through market cycles. | According to the CirclFi Deep Alpha Valuation Engine, the ML Residual Income model sees the stock as overvalued with a fair value of $1.76 (-41.0%), suggesting that the market price embeds overly optimistic growth assumptions. |
| According to the CirclFi Deep Alpha Valuation Engine, the stock shows multi-model upside with a median implied return of +148.9% across 9 bullish models from the current price of $2.98. | According to the CirclFi Deep Alpha Valuation Engine, the wide model spread of +357.4% reflects fundamental divergence on key assumptions (growth, cost of capital) depending on the methodology. |
| According to the CirclFi Deep Alpha Valuation Engine, the RCMH-DCF model targets a fair value of $12.41 (+316.4%), anchoring the bull case with a methodology that provides a differentiated analytical lens. | Industry headwind: regulatory rejection risk represents a meaningful risk for SIGA Technologies, Inc. and its Drug Manufacturers - Specialty & Generic peers. |
| Industry tailwind: late-stage pipeline catalysts could provide meaningful support for SIGA Technologies, Inc.'s revenue and margin trajectory in the Drug Manufacturers - Specialty & Generic space. |
How Does SIGA Compare to Its Drug Manufacturers - Specialty & Generic Peers?
Valuation data pages: BCRX · PBH · ETST · AMRX · HLN · KNSA · ALVO · CVSI · PTPI · UTHR · AMPH
See full Drug Manufacturers - Specialty & Generic rankings →
Which Other Stocks Score Like SIGA on Quality?
Closest companies to SIGA’s Quality of Company score of 8.4/10, across all industries.
- QCRH — QCR Holdings, Inc. (QOC 8.4) · analysis
- NWSA — News Corporation (QOC 8.4) · analysis
- ACA — Arcosa, Inc. (QOC 8.4) · analysis
- CHTR — Charter Communications, Inc. (QOC 8.4) · analysis
- VLO — Valero Energy Corporation (QOC 8.4) · analysis
- PKE — Park Aerospace Corp. (QOC 8.4) · analysis
- NVDA — NVIDIA Corporation (QOC 10.0) · analysis
Which Drug Manufacturers - Specialty & Generic Screens Does SIGA Appear In?
So Is SIGA Technologies, Inc. (SIGA) Worth Buying in 2026?
The convergence of 8.4/10 quality, multi-model undervaluation (9/10 bullish, +148.9% median upside), and a median fair value of $7.42 vs. $2.98 current price makes SIGA Technologies, Inc. one of the more compelling opportunities in our coverage. As always, our models provide a quantitative starting point — not a substitute for individual due diligence.
These are quantitative model outputs, not investment recommendations. SIGA Technologies, Inc.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
What Else Do Investors Ask About SIGA Stock?
Should I buy SIGA stock right now?
Based on CirclFi's multi-model analysis, 9 of 10 models see upside for SIGA at $2.98. The majority of models suggest the stock trades below fair value, but investors should weigh this against the Quality Score of 8.4/10 and individual risk tolerance. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in SIGA Technologies, Inc.?
Key risks include: wide model disagreement (606% spread), signaling high uncertainty; general market and sector-specific risks affecting Drug Manufacturers - Specialty & Generic companies. Always diversify and consult a financial advisor.
How does SIGA compare to its competitors?
Among Drug Manufacturers - Specialty & Generic peers, SIGA holds a Quality Score of 8.4/10. Comparable companies include BCRX (QOC 8.4), PBH (QOC 8.3), ETST (QOC 8.5). The relative ranking helps investors identify whether SIGA offers better fundamental quality than alternatives in the same sector.
Is SIGA a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. SIGA's Quality Score of 8.4/10 is encouraging for long-term holders, indicating consistent profitability, manageable debt, and healthy cash flows. Check our full data page for all 13 model estimates.
What price should I buy SIGA at?
CirclFi does not provide target buy prices or price alerts. However, our 10 active models produce fair value estimates ranging from $1.76 to $12.41. At $2.98, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for SIGA.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →
Buy with Gumroad